Health ❯Neurodegenerative Diseases ❯Amyotrophic Lateral Sclerosis (ALS)
UPRBax Apoptosis Inhibitor
Allegations focus on misleading statements about RELYVRIO®'s commercial prospects, leading to significant stock price drop.
